Form 4: Neogen CEO John Edward Adent Exercises Restricted Stock Units
SEC Form 4 Filing
Neogen CEO John Edward Adent exercised restricted stock units (RSUs) on April 28, 2025, converting them into common stock.
Summary
- On April 29, 2025, a Form 4 filing was submitted to the SEC regarding a transaction by John Edward Adent, CEO of Neogen Corp.
- The transaction involved the exercise of 2,112 Restricted Stock Units (RSUs) at a price of $5.16 each on April 28, 2025.
- These RSUs vested and were settled for an equal number of shares of common stock on the same day.
- Following the transaction, Adent directly owns 271,276 shares of Neogen Corp. common stock and 4,224 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard transaction related to executive compensation.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction reflects the standard vesting and exercise of equity compensation.
Key Dates
| Date | Description |
|---|---|
| 04/28/2025 | Date of RSU transaction, vesting, and settlement for common stock. |
| 04/29/2025 | Date of Form 4 filing. |
Keywords
Form 4, SEC, Neogen Corp, John Edward Adent, Restricted Stock Units, RSU, Common Stock, Beneficial Ownership, Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.